3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
49
Phase 1/2
3
Phase 3
2
Phase 1
2
Status
Unknown
1
Recruiting
1
Sponsor Class
INDUSTRY
11
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, B-Cell
1
Autoimmune Diseases of the Nervous System
1
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
1
Interventions
Cisplatin
294
Radiotherapy
230
Fluorouracil
201
Cyclophosphamide
191
Capecitabine
182
Docetaxel
166
Gemcitabine
165
Oxaliplatin
162
Carboplatin
160
Paclitaxel
152
Leucovorin
122
Drug Therapy
118
Dexamethasone
118
Doxorubicin
112
Etoposide
99
Bevacizumab
91
Cytarabine
87
Vincristine
83
Irinotecan
81
Rituximab
77
Epirubicin
71
Prednisone
65
Radiosurgery
63
Methotrexate
62
Surgical Procedures, Operative
61
Radiation
60
Radiotherapy, Intensity-Modulated
56
Neoadjuvant Therapy
53
Lenalidomide
52
Letrozole
50
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER
×
ofatumumab
×
Clear all
NCT06867991
2025-07-15
RADIA
The First People's Hospital of Changzhou
Phase 3
Recruiting
200 enrolled
NCT01678430
2012-10-15
RIAltO
University of Liverpool
Phase 3
Unknown
670 enrolled